% alzhub.org topic: intravenous
% Source: https://alzhub.org/topic/intravenous
% 3 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{menendezgonzalez2025-39851481,
  author  = {Menendez-Gonzalez, M.},
  title   = {{Targeting Soluble Amyloid Oligomers in Alzheimer's Disease: A Hypothetical Model Study Comparing Intrathecal Pseudodelivery of mAbs Against Intravenous Administration}},
  journal = {Diseases (Basel, Switzerland)},
  year    = {2025},
  doi     = {10.3390/diseases13010017},
  pmid    = {39851481},
  url     = {https://doi.org/10.3390/diseases13010017}
}

@article{liu2019-31092051,
  author  = {Liu, J. and Wang, L. N.},
  title   = {{Intravenous immunoglobulins for Alzheimer's disease and mild cognitive impairment due to Alzheimer's disease: A systematic review with meta-analysis}},
  journal = {Expert review of neurotherapeutics},
  year    = {2019},
  doi     = {10.1080/14737175.2019.1620106},
  pmid    = {31092051},
  url     = {https://doi.org/10.1080/14737175.2019.1620106}
}

@article{relkin2009-18294736,
  author  = {Relkin, N. R. and Szabo, P. and Adamiak, B. and Burgut, T. and Monthe, C. and Lent, R. W. and Younkin, S. and Younkin, L. and others},
  title   = {{18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease}},
  journal = {Neurobiology of aging},
  year    = {2009},
  doi     = {10.1016/j.neurobiolaging.2007.12.021},
  pmid    = {18294736},
  url     = {https://doi.org/10.1016/j.neurobiolaging.2007.12.021}
}